Association Between the Percentage of US Drug Sales Subject to Inflation Penalties and the Extent of Drug Price Increases

IMPORTANCE: Policy makers have proposed levying penalties for drug price increases that are higher than the rate of inflation for drugs covered in the US Medicare program, but research is lacking regarding the ways in which manufacturers might respond to those penalties. An understanding of manufact...

Descripción completa

Detalles Bibliográficos
Autor principal: Dickson, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489845/
https://www.ncbi.nlm.nih.gov/pubmed/32915237
http://dx.doi.org/10.1001/jamanetworkopen.2020.16388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489845/
https://www.ncbi.nlm.nih.gov/pubmed/32915237
http://dx.doi.org/10.1001/jamanetworkopen.2020.16388

Ejemplares similares